ReNeuron Group Plc Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and ReNeuron Group are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ReNeuron Group Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, ReNeuron Group is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 14.7 M | |
| Total Cashflows From Investing Activities | -276 K |
ReNeuron |
ReNeuron Group Relative Risk vs. Return Landscape
If you would invest (100.00) in ReNeuron Group Plc on October 15, 2025 and sell it today you would earn a total of 100.00 from holding ReNeuron Group Plc or generate -100.0% return on investment over 90 days. ReNeuron Group Plc is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than ReNeuron, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
ReNeuron Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ReNeuron Group's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as ReNeuron Group Plc, and traders can use it to determine the average amount a ReNeuron Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| RNUGF |
Based on monthly moving average ReNeuron Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ReNeuron Group by adding ReNeuron Group to a well-diversified portfolio.
ReNeuron Group Fundamentals Growth
ReNeuron Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of ReNeuron Group, and ReNeuron Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ReNeuron Pink Sheet performance.
| Return On Equity | -0.72 | |||
| Return On Asset | -0.33 | |||
| Operating Margin | (12.05) % | |||
| Current Valuation | (5.04 M) | |||
| Shares Outstanding | 57.17 M | |||
| Price To Earning | (5.33) X | |||
| Price To Book | 1.37 X | |||
| Price To Sales | 15.15 X | |||
| Revenue | 403 K | |||
| EBITDA | (10.71 M) | |||
| Cash And Equivalents | 14.55 M | |||
| Cash Per Share | 0.25 X | |||
| Total Debt | 562 K | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (7.41 M) | |||
| Earnings Per Share | (0.23) X | |||
| Total Asset | 17.32 M | |||
| Retained Earnings | (80 M) | |||
| Current Asset | 63 M | |||
| Current Liabilities | 5 M | |||
Things to note about ReNeuron Group Plc performance evaluation
Checking the ongoing alerts about ReNeuron Group for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for ReNeuron Group Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ReNeuron Group Plc is not yet fully synchronised with the market data | |
| ReNeuron Group Plc has some characteristics of a very speculative penny stock | |
| ReNeuron Group Plc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 403 K. Net Loss for the year was (9.69 M) with loss before overhead, payroll, taxes, and interest of (7.67 M). | |
| ReNeuron Group Plc has accumulated about 14.55 M in cash with (7.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25. | |
| Roughly 19.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing ReNeuron Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ReNeuron Group's stock is overvalued or undervalued compared to its peers.
- Examining ReNeuron Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ReNeuron Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ReNeuron Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ReNeuron Group's pink sheet. These opinions can provide insight into ReNeuron Group's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in ReNeuron Pink Sheet
If you are still planning to invest in ReNeuron Group Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ReNeuron Group's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |